Anti-human CD34 Antibody |产品详情|进口试剂采购网

您好，欢迎来到拜力生物网站！请登录注册

我的订单 | 联系我们 | 在线客服QQ：3012681483 | 客服电话：400-968-7988 | 工作时间：08:30-17:30

主营产品： ELISA试剂盒、抗体、补体血清、兔补体、干扰素、小鼠测温仪、进口试剂、Quidel代理、Swant代理、PBL Assay Science代理

网站首页产品中心代理品牌新闻资讯资源中心关于我们

所在位置：首页 > 产品中心 > abmgood > abmgood产品

订购信息

上海拜力生物科技公司

Tel:400-968-7988 021-33779008

Anti-human CD34 Antibody

品牌：Abmgood

货号：

规格：

货期：

应用：

咨询客服

立即购买加入购物车

Anti-human CD34 Antibody

商品详情参考文献相关资料

Overview	Print Version
Product Name	Anti-human CD34 Antibody
Description	mAb name/Clone: 43A1 Human CD34 is an unusual glycosylated membrane protein exclusively expressed on immature hematopoietic cells and on endothelial cells. CD34 may have a role in cell adhesion. CD34 has extensive utility for bone marrow transplantation. Antibody 43A1 recognizes a class 2 epitope of the 110 kd CD34 molecule.
Subtype	monoclonal
Application	IP,Flow Cyt,other
Raised In	mouse
Specificity	Antibody 43A1 recognizes a class 2 epitope of the 110 kd CD34 molecule (1, 2).
Immunogen	Human KG-1a tumor cells
Guarantee	abm guarantees that all our Anti-human CD34 Antibody will perform as described on this product webpage, if this is not the case we will provide you with a one-time replacement at no extra cost. Documentation and explanation of experiment conducted will be required when submitting a claim for replacement.
Properties
Formulation	Liquid
Quantity	100 μl
Clone	Monoclonal
Storage	This product is stable for several weeks at 4°C as an undiluted liquid. Dilute only prior to immediate use. For extended storage, aliquot contents and freeze at -20°C or below. Avoid cycles of freezing and thawing. Expiration date is one (1) year from date of receipt.
Storage Buffer	PBS, pH 7.4 with 0.02% sodium azide.
Concentration	1µg/ul
Purity	Protein A Purified
Isotype	IgG3 kappa
Species Reactivity	human
Specific References
Y077039 has been referenced in 1 publication. 1. H.J. BÃ¼hring, et al, (1991) Leukemia 5: 854-860. 2. Leukocyte Typing V (S.F. Schlossman, et al, eds.) Oxford University Press, Oxford, (1995) p. 840-874. 3. R.H. Collins, (1994) Stem Cells 12: 577-585. 4. T.L. Holyoake & M.J. Alcorn, (1994) Blood Reviews 8: 113-124. 5. J.P. Levesque, L.J. Bendell, et al. (2003) J Clin Invest 110: 187-196. 6. F Lanza, D.R. Sutherland, et al. (2001) 15: 1-13.